Wu, Chenglin <br/><br/>
Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia.  [electronic resource] 

 -  Acta pharmaceutica Sinica. B  Nov 2019 
 - 1216-1230 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2211-3835 
<br/><br/><label>Standard No.: </label>10.1016/j.apsb.2019.06.006  doi